MVP signs new Manufacturing Development Project with CSIRO

Medical Developments International Limited (ASX: MVP) is delighted to announce it has signed an extension to the 2017 agreement with Australia’s national science agency, the Commonwealth Scientific and Industrial Research Organisation (CSIRO), to develop new manufacturing technologies for pharmaceutical products.

This agreement extends MVP’s existing partnership with CSIRO and the technologies developed in that partnership.  Our collective ambition is to develop the next generation of manufacturing technologies to make ‘small molecule’ pharmaceutical products at a significantly reduced cost and improved quality, compared with traditional processes.